These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 16232091
1. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Fernández-Suárez A, Reneses S, Wichmann I, Criado R, Núñez A. Clin Chem Lab Med; 2005; 43(11):1234-9. PubMed ID: 16232091 [Abstract] [Full Text] [Related]
2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [Abstract] [Full Text] [Related]
4. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis]. Cho SY, Kang SY, Lee HJ, Lee WI. Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254 [Abstract] [Full Text] [Related]
5. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712 [Abstract] [Full Text] [Related]
6. Performance evaluation of Elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available ELISA assays in rheumatoid arthritis diagnosis. Cai B, Wang L, Liu J, Feng W. Clin Biochem; 2011 Aug; 44(12):989-93. PubMed ID: 21640094 [Abstract] [Full Text] [Related]
7. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A, Plischke H, Kellner H, Gruber R. Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [Abstract] [Full Text] [Related]
8. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S. J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [Abstract] [Full Text] [Related]
9. Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls. Pyun JC, Lee EH, Han H, Kim HY, Kim HO, Kang MJ. J Pharm Biomed Anal; 2014 Apr; 92():69-73. PubMed ID: 24503194 [Abstract] [Full Text] [Related]
10. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F. J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [Abstract] [Full Text] [Related]
11. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R, Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators. Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488 [Abstract] [Full Text] [Related]
12. Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC. J Korean Med Sci; 2005 Jun; 20(3):473-8. PubMed ID: 15953872 [Abstract] [Full Text] [Related]
13. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. Maraina CH, Nurdayana AK, Rusni D, Azwany Y. Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468 [Abstract] [Full Text] [Related]
14. [Diagnostic utility of AxSYM anti-cyclic Citrullinated peptide antibody assay]. Kim KE, Kim KH, Woo KS, Han JY, Kim JM, Lee SW, Chung WT. Korean J Lab Med; 2008 Dec; 28(6):457-64. PubMed ID: 19127111 [Abstract] [Full Text] [Related]
15. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, Batteux F, Dougados M, Kahan A, Allanore Y. J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898 [Abstract] [Full Text] [Related]
17. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients. Zhu T, Feng L. Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638 [Abstract] [Full Text] [Related]
18. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D, Gülmez D, Hasçelik G. Mikrobiyol Bul; 2003 Apr; 37(2-3):163-70. PubMed ID: 14593899 [Abstract] [Full Text] [Related]
19. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T. J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947 [Abstract] [Full Text] [Related]
20. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]